Basic Information
NodThera is a biotechnology company dedicated to developing novel, effective, and selective NLRP3 inflammasome inhibitors for the treatment of diseases caused by chronic inflammation. Led by an experienced management team, NodThera will leverage new insights into inflammasome biology and chemistry to build a highly differentiated platform.
NodThera Limited
England,United Kingdom
15~50 people
January 01, 2016
info@nodthera.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios